Abstract
BACKGROUND Uveal melanoma is the most common primary intraocular malignancy in adults, often diagnosed late in resource-limited settings. The diagnosis is made through a combination of clinical ophthalmologic examination, B-mode ultrasound, and histopathological study. This report details a case of a 67-year-old woman with progressive vision loss and ocular pain due to an inferomedial uveal melanoma to highlight therapeutic limitations from delayed diagnosis. CASE REPORT A 67-year-old woman presented with 3 years of progressive vision loss, ocular pain, and a pigmented inferomedial lesion in the right eye. Examination revealed light perception vision, intraocular pressure of 38 mmHg, and a conjunctival mass with feeder vessels. Ultrasound showed a large choroidal tumor occupying 70% of the vitreous. Enucleation confirmed a 19-mm-thick mixed-cell uveal melanoma (T4a per American Joint Committee on Cancer 8th edition) with scleral invasion. Postoperative computed tomography (CT) revealed no metastases. CONCLUSIONS Delayed presentation led to enucleation as the only viable treatment. This case underscores the critical need for public awareness, early detection, and effective referral systems of pigmented ocular lesions to preserve vision, expand therapeutic options, and ensure timely access to specialized care.